Q4 2025 Treace Medical Concepts Inc Earnings Call Transcript
Key Points
- Treace Medical Concepts Inc (TMCI) has expanded its product offerings, now addressing virtually 100% of surgeons' technique preferences for bunion correction.
- The company reported a significant reduction in cash burn for 2025, using $27.3 million compared to $50.5 million in 2024, a 46% decrease.
- Treace Medical Concepts Inc (TMCI) has seen rapid adoption of its new bunion systems, with over 25% of its surgeon base incorporating these into their practice.
- The company plans to launch additional products in 2026, expanding its total addressable market (TAM) by an estimated $300 million.
- Treace Medical Concepts Inc (TMCI) has a strong and flexible balance sheet, with $48.4 million in cash, cash equivalents, and marketable securities as of December 31, 2025.
- Revenue in the fourth quarter of 2025 decreased by 9% compared to the prior year period, driven by a shift towards lower-priced products.
- The company reported a net loss of $9.4 million in the fourth quarter of 2025, compared to a net loss of $0.5 million in the fourth quarter of 2024.
- Treace Medical Concepts Inc (TMCI) expects revenue declines to continue until the fourth quarter of 2026.
- The company anticipates a loss in adjusted EBITDA in the range of $4 million to $6 million for the full year 2026.
- Broader economic conditions and softer consumer sentiment are expected to continue impacting the company's performance in 2026.
Good day, and thank you for standing by. Welcome to the Treace Medical Concepts fourth quarter and full year 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions) I would now like to hand the conference over to your speaker today, Trip Taylor, Investor Relations
Good morning, everyone, and welcome to our fourth quarter 2025 earnings conference call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, Chief Financial Officer. John and Mark will discuss our fourth quarter financial results and 2026 outlook.
We will then host a question-and-answer session following our prepared remarks. Our press release can be found in the Investor Relations section of our website at investors.crescom. This call is being recorded and will be archived in the Investors section of our website.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
